CJMY
Sunfert International Fertility Centre (Sunfert), renowned for its patient-centred approach, advanced fertility treatments, and innovative payment schemes, has once again achieved international recognition.
Sunfert was named the ‘Fertility Centre of The Year in Asia Pacific’ for the second time at the GlobalHealth Asia-Pacific Awards 2023. Additionally, the centre secured the ‘Excellence in Patient Service Provider of The Year in the Asia Pacific award, further cementing its position as a leader in the field.
With over 5,000 babies brought into the world through their advanced fertility treatments, Sunfert celebrates these prestigious accolades.
Excellence in patient services and a patient-centred approach
Lakshmi Menon, the General Manager of Sunfert Group, highlighted the centre’s commitment to patient outcomes and service excellence.
Understanding the emotional journey couples experience while trying to conceive or expand their families, Sunfert has assembled a dedicated team of medical professionals, including experienced fertility specialists, nurses, and support staff. By fostering open communication, Sunfert aims to create a supportive and empowering environment throughout each patient’s fertility journey.
All of Sunfert’s branches hold accreditation from the Reproductive Technology Accreditation Committee (RTAC), demonstrating the centre’s dedication to patient-centred fertility care that prioritizes safety and quality throughout the treatment process.
Innovation and expansion of Sunfert
Since its inception in 2009, Sunfert has been at the forefront of fertility innovation. The centre operates a one-stop fertility facility with its genetic testing laboratory, enabling faster results and stringent in-house quality control.
Located in Bangsar South, Kuala Lumpur, the flagship centre offers state-of-the-art medical technology, including an in-house genetic testing laboratory for precise pre-implantation genetic testing procedures. Sunfert has expanded its reach with additional branches in Ipoh, Seremban, and Kuching, with plans for further expansion within Malaysia and the Southeast Asian region.
In 2020, Sunfert achieved another significant milestone by establishing Malaysia’s first private Oncofertility hub. Through a cutting-edge technology called Ovarian Tissue Cryopreservation, women and pre-pubertal girls can preserve their ovarian tissues before undergoing cancer treatment. This allows them to safeguard their reproductive potential and fulfil their desire for a family when they are ready.
Sunfert’s remarkable achievements not only underscore its success but also reinforce Malaysia’s leading position in fertility services in Asia. The recognition received at the GlobalHealth Asia-Pacific Awards 2023 further solidifies Sunfert’s contribution to the nation’s healthcare tourism sector. While the majority of patients come from Malaysia, Sunfert is also sought after by patients from various countries worldwide.
The centre’s commitment to accessibility is reflected in its payment options, including cashless payment through EPF (Employee Provident Fund) Account 2 and the government’s tax relief incentive of up to RM8,000 for fertility treatments. These initiatives aim to alleviate the financial burden on couples, providing a hassle-free IVF journey.
For more information, visit www.sunfert.com
Admin
